Nutex Health Inc. (NUTX) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the NewTex Health Shareholders Update conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Vivian Sanders, Corporate Director of Marketing and Business Development. Thank you. You may begin. Good morning, everyone, and welcome to Nutex Health Inc's second quarter 2025 company update conference call. I'm Vivian Sanders, and I'm pleased to moderate today's discussion. Thank you for joining us as we review our performance and outline our plans for the future. This call is being recorded, and a replay will be available on our website. With me today are our key leaders, Dr. Tom Vo, Chairman and CEO, John Bates, Chief Financial Officer, Dr. Warren Hossinian, President, and Dr. Mike Chang, Chief Medical Officer. They will provide insights into our financial results, operational progress, clinical quality, and strategic direction, followed by a Q&A session. Before we begin, a few reminders. Today's discussion may include forward-looking statements based on management's current expectations. These are subject to risks and uncertainties that could cause actual results to differ. For details, please refer to our press release and form 8K filed last week and our other SEC filings. These preliminary results being presented today remain subject to the completion of normal quarter end and fiscal end accounting procedures and closing statement adjustments. and the quarterly review process conducted by our auditors. With that, I'm pleased to turn the call o...